Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
1 hedge funds and large institutions have $1K invested in Anthera Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
80% less funds holding
Funds holding: 5 → 1 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
95% less capital invested
Capital invested by funds: $18.7K → $1K (-$17.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Vigilant Capital Management
Portland,
Maine
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
-$17K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$1K |
| 3 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$714 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VCM
1
Vigilant Capital Management
Portland,
Maine
| $1K | +$1K | +10,000 | New |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| – | -$17K | -210,914 | Closed |
|
|
3
California Public Employees Retirement System
Sacramento,
California
| – | -$1K | -12,765 | Closed |
|
|
MAM
4
Meeder Asset Management
Dublin,
Ohio
| – | -$714 | -9,035 | Closed |
|
ANTH Hedge Fund Activity: Q3 2018 in Review
1 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q3 2018, worth a combined $1K — down 95% from $18.7K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ANTH and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Vigilant Capital Management, opening a new position worth an estimated $1K. The largest seller was Wedbush Securities, exiting entirely with an estimated $17K sold.
- 1 institutional investor held Anthera Pharmaceuticals, Inc. (ANTH) as of Q3 2018, down from 5 in Q2 2018.
- Funds reported $1K of Anthera Pharmaceuticals, Inc. stock for Q3 2018, down 95% quarter-over-quarter.
- 1 fund opened new Anthera Pharmaceuticals, Inc. positions in Q3 2018 and 5 closed out, a net change of -4 holders.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q3 2018 was Vigilant Capital Management, an estimated $1K added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q3 2018 was Wedbush Securities, an estimated $17K sold.
Based on aggregated 13F filings for Q3 2018.